THE EFFECT OF HISTONE DEACETYLASE INHIBITOR ENTINOSTAT ON INVASION AND MIGRATION OF LUNG CANCER

被引：0
|
作者：
Zeng, Yunlong [1 ]
Xiong, Qingqing [2 ]
Wang, Tao [3 ]
机构：
[1] Jiangxi Chest Hosp, Dept Pharm, Nanchang 330006, Jiangxi, Peoples R China
[2] Jiangxi Chest Hosp, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China
[3] Jiangxi Chest Hosp, Dept Surg, Nanchang 330006, Jiangxi, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
53
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [31] Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
    Takai, Noriyuki
    Narahara, Hisashi
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [32] Characterization of the class 1 histone deacetylase inhibitor entinostat in EGFRi acquired resistance models and in combination with cetuximab in NSCLC
    Chan, Daniel C.
    Witta, Samir E.
    Zheng, Di
    Franekova, Veronika
    Sui, Xiaomei
    Ordentlich, Peter
    Bunn, Paul A.
    Hirsch, Fred R.
    CANCER RESEARCH, 2010, 70
  • [33] A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors
    Nuttapong Ngamphaiboon
    Grace K. Dy
    Wen Wee Ma
    Yujie Zhao
    Thanyanan Reungwetwattana
    Dawn DePaolo
    Yi Ding
    William Brady
    Gerald Fetterly
    Alex A. Adjei
    Investigational New Drugs, 2015, 33 : 225 - 232
  • [34] The Effect of Histone Deacetylase Inhibitors Panobinostat or Entinostat on Motor Recovery in Mice After Ischemic Stroke
    Abdullah Al Shoyaib
    Faisal F. Alamri
    Nausheen Syeara
    Srinidhi Jayaraman
    Serob T. Karamyan
    Thiruma V. Arumugam
    Vardan T. Karamyan
    NeuroMolecular Medicine, 2021, 23 : 471 - 484
  • [35] A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors
    Ngamphaiboon, Nuttapong
    Dy, Grace K.
    Ma, Wen Wee
    Zhao, Yujie
    Reungwetwattana, Thanyanan
    DePaolo, Dawn
    Ding, Yi
    Brady, William
    Fetterly, Gerald
    Adjei, Alex A.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (01) : 225 - 232
  • [36] Effect of a Histone Deacetylase Inhibitor on Human Cardiac Mass
    Yukitaka Shizukuda
    Richard L. Piekarz
    Susan E. Bates
    Vandana Sachdev
    Toren Finkel
    Douglas R. Rosing
    Cardiovascular Drugs and Therapy, 2005, 19 : 89 - 90
  • [37] Effect of a histone deacetylase inhibitor on human cardiac mass
    Shizukuda, Y
    Piekarz, RL
    Bates, SE
    Sachdev, V
    Finkel, T
    Rosing, DR
    CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (01) : 89 - 90
  • [38] Metabolic profile of lung cancer cell lines treated with histone deacetylase inhibitor sodium butyrate
    Amoedo, Nivea D.
    Rodrigues, Mariana F.
    Costa, Leandro
    Pezzuto, Paula
    Giannini, Ana L. M.
    da Costa, Rodrigo F. M.
    Benchimol, Marlene
    Porto, Tatiana El-Bacha
    Almeida, Fabio C. L.
    Galina Filho, Antonio
    Rumjanek, Franklin D.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S11 - S11
  • [39] Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer
    Schech, Amanda J.
    Shah, Preeti
    Yu, Stephen
    Sabnis, Gauri J.
    Goloubeva, Olga
    Rosenblatt, Paula
    Kazi, Armina
    Chumsri, Saranya
    Brodie, Angela
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 499 - 508
  • [40] Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer
    Amanda J. Schech
    Preeti Shah
    Stephen Yu
    Gauri J. Sabnis
    Olga Goloubeva
    Paula Rosenblatt
    Armina Kazi
    Saranya Chumsri
    Angela Brodie
    Breast Cancer Research and Treatment, 2015, 152 : 499 - 508
12345